The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 27, 2015
Filed:
Jun. 01, 2011
Applicants:
Terrance Grant Johns, Box Hill North Victoria, AU;
Ermanno Gherardi, Pavia, IT;
Andrew Mark Scott, Kew East Victoria, AU;
Inventors:
Terrance Grant Johns, Box Hill North Victoria, AU;
Ermanno Gherardi, Pavia, IT;
Andrew Mark Scott, Kew East Victoria, AU;
Assignees:
Ludwig Institute for Cancer Research, New York, NY (US);
Monash University, Clayton, Victoria, AU;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/40 (2006.01); A61K 39/395 (2006.01); G01N 33/74 (2006.01); C07K 16/28 (2006.01); A61K 45/06 (2006.01); C07K 14/705 (2006.01);
U.S. Cl.
CPC ...
C07K 16/40 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); C07K 14/705 (2013.01); C07K 16/2803 (2013.01); G01N 33/74 (2013.01); C07K 2317/34 (2013.01); C07K 2317/56 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01);
Abstract
The present invention relates to antibodies that specifically bind to unprocessed c-Met present on the surface of tumor cells. These antibodies are useful in the diagnosis and treatment of cancer or as agents for delivering moieties to cancer cells. The antibodies of the present invention may also be used in therapy in combination with chemotherapeutics or anti-cancer agents.